Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
Commentary|Podcasts|August 25, 2023
ESG Evolution
Author(s)Nicholas Saraceno, Senior Editor
In this PC Podcast episode, Susanne Katus discusses the increasing number of regulations impacting both pharma and biotech companies.
Advertisement
In this exclusive PC Podcast interview, Susanne Katus, SVP, market leader, corporate secretary at Datamaran, a platform that monitors and analyzes risk factors, dives into:
- The growing number of environmental, social, and governance (ESG) regulations impacting these aforementioned businesses
- Where the responsibility lies for them in terms of ESG compliance
- What can be done in order for these corporations to be ahead of the game
- Why ESG should be a top priority
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Advertisement
Related to this article
In this week's Pharma Pulse, DHL breaks ground on a new cold chain hub at Singapore's Changi Airport, a new report finds pharma's commercial model in the middle of a fundamental reset, and the FDA grants accelerated approval to sevabertinib.
In this week's Pharma Pulse, nine more drugmakers join the MFN program, GoodRx adds a family plan, IPC formalizes its USave partnership, and CSafe expands its thermal cover offerings.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
White House Extends MFN Pricing to Every State Medicaid Program
2
Pharma Pulse: Behind the Scenes of LogiPharma USA 2026
3
How Rebate Timing Distorts a Pharmacy's 340B Books
4
Pharma Pulse: Independent Pharmacies Sue Express Scripts, Novo Taps Anthropic, Pharma Joins Clean Heat
5